Speaker

Marvin Gee

Chief Research Officer & Co-Founder, 3T Biosciences

Marvin Gee, Chief Research Officer & Co-Founder at 3T Biosciences, spoke at 2nd T-Cell Engager for Autoimmune Disease Summit (Boston, United States of America, 27–29 Oct 2026) in the session “Unlocking Novel Autoimmune Therapeutic Opportunities Through Precision Peptide-HLA Target Discovery & Immune Modulation”.

Conferences: 1
Keynotes: 0
Upcoming: 0

Past appearances

2nd T-Cell Engager for Autoimmune Disease Summit
27–29 Oct 2026Boston, United States of America
- SpeakerUnlocking Novel Autoimmune Therapeutic Opportunities Through Precision Peptide-HLA Target Discovery & Immune Modulation
- PanelRoundtable Discussion: Identifying the Most Promising Precision Targets to Shape the Next Generation of Autoimmune T-Cell EngagersWith Karsten Sauer, Ariel Guo

More speakers at 2nd T-Cell Engager for Autoimmune Disease Summit

Mike Jones
Search & Evaluation Lead, GI & Inflammation, Strategy & Portfolio Development, Takeda Pharmaceutical
Giovanni Abbadessa
Chief Medical Officer, ModeX Therapeutics
Patrick Baeuerle
Chief Scientific Advisor & Chairman of Scientific Advisory Board, Cullinan Therapeutics, Inc.
Xingfeng Bao
Senior Vice President & Head of Research, GV20 Therapeutics LLC
Alexander Boches
Chief Business Officer, NovalGen
Elaine Chen
Senior Scientist, Translational Biology, Rondo Therapeutics

See all 19 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Marvin Gee, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].